Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs.

Journal: International journal of medical informatics
Published Date:

Abstract

INTRODUCTION: Advances in artificial intelligence offer the promise of automated analysis of optical coherence tomography (OCT) scans to detect ocular complications from anticancer drug therapy. To explore how such AI outputs are interpreted in clinical settings, we conducted a survey-based interview study with 27 clinicians -comprising 10 ophthalmic specialists, 10 ophthalmic practitioners, and 7 oncologists. Participants were first introduced to core AI concepts and realistic clinical scenarios, then asked to assess AI-generated OCT analyses using standardized Likert-scale questions, allowing us to gauge their understanding, trust, and readiness to integrate AI into practice.

Authors

  • Oskar Wysocki
    Cancer Research UK Manchester Institute, University of Manchester, Oxford Rd, Manchester M13 9PL, United Kingdom; Idiap Research Institute, National University of Sciences, Rue Marconi 19, CH - 1920 Martigny, Switzerland.
  • Sammie Mak
    St.Jame's University Hospital, Beckett St, Harehills, Leeds LS9 7TF, United Kingdom; Leeds Teaching Hospitals NHS Trust, Great George St, Leeds LS13EX, United Kingdom.
  • Hannah Frost
    Cancer Research UK Manchester Institute, University of Manchester, Oxford Rd, Manchester M13 9PL, United Kingdom.
  • Donna M Graham
    Cancer Research UK Manchester Institute, University of Manchester, Oxford Rd, Manchester M13 9PL, United Kingdom; The Christie HNS Foundation Trust, Wilmslow Rd, Manchester M204BX, United Kingdom.
  • Dónal Landers
    DeLondra Oncology Ltd, 38, Carlton Avenue, Wilmslow SK9 4EP, United Kingdom.
  • Tariq Aslam
    Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, United Kingdom; School of Health Sciences, University of Manchester, Oxford Road, Manchester M139PL, United Kingdom. Electronic address: tariq.aslam@manchester.ac.uk.